Updated Mar 21, 2026 by Towa Pharmaceutical
The financial reporting period for this document concludes on March 31, 2025.
Towa Pharmaceutical, J-Dolph Pharmaceutical, Daichi Kasei, Greencaps Pharmaceutical, and Kyushu Iyaku are collectively categorized as 'Towa Pharmaceutical, etc.' for domestic segment reporting.
Sunsho Pharmaceutical, KAMATA, and Sun Freres Lab are identified as distinct entities within the company's organizational structure for financial reporting purposes.
The financial reporting period for this document concludes on March 31, 2025.
Towa Pharmaceutical, J-Dolph Pharmaceutical, Daichi Kasei, Greencaps Pharmaceutical, and Kyushu Iyaku are collectively categorized as 'Towa Pharmaceutical, etc.' for domestic segment reporting.
Sunsho Pharmaceutical, KAMATA, and Sun Freres Lab are identified as distinct entities within the company's organizational structure for financial reporting purposes.